| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 2022 | RBOT Vicarious Surgical Inc. | Khalifa Sammy84 | Chief Technology Officer | Sell | 4,551 | $4.17 | $18,981.77 | -0.4% | -44.3% | -80.6% | |
| Sep 15, 2022 | BSX Boston Scientific Corp | Carruthers Wendy | EVP, Human Resources | Sell | 7,500 | $42.21 | $316,585.50 | -6.4% | +11.8% | +25.4% | |
| Sep 15, 2022 | MASS 908 Devices Inc. | Knopp Kevin J.79 | President And CEO | Sell | 30,000 | $16.94 | $508,200.00 | -5.4% | -47.0% | -62.1% | |
| Sep 15, 2022 | RMD Resmed Inc | Farrell Michael J.63 | Chief Executive Officer | Sell | 5,675 | $228.96 | $1,299,336.08 | -1.3% | -2.1% | -35.5% | |
| Sep 15, 2022 | LUNG Pulmonx Corp | French Glendon E. III84 | President And CEO | Sell | 25,000 | $20.00 | $500,000.00 | -2.4% | -65.4% | -47.5% | |
| Sep 15, 2022 | RMD Resmed Inc | Douglas Robert Andrew71 | President And COO | Sell | 17,189 | $232.47 | $3,995,863.48 | -6.3% | -2.1% | -35.5% | |
| Sep 15, 2022 | HAE Haemonetics Corp | Basil Michelle L51 | EVP And General Counsel | Sell | 33,798 | $77.89 | $2,632,593.94 | -30.6% | +4.8% | +16.1% | |
| Sep 15, 2022 | ATRC Atricure, Inc. | Doraiswamy Vinayak70 | Chief Scientific Officer | Sell | 4,983 | $45.99 | $229,168.17 | -20.4% | -4.3% | -2.7% | |
| Sep 15, 2022 | CNMD Conmed Corp | Hartman Curt R66 | President, CEO And Chair | Sell | 3,500 | $93.94 | $328,776.00 | -25.4% | +0.6% | +16.5% | |
| Sep 15, 2022 | RBOT Vicarious Surgical Inc. | Liang Philip45 | Director | Sell | 13,300 | $4.26 | $56,657.05 | -0.5% | -44.3% | -80.6% | |
| Sep 14, 2022 | TMCI Treace Medical Concepts, Inc. | Treace James T53 | Director | Sell | 50,000 | $23.03 | $1,151,416.17 | -2.1% | -0.1% | -36.8% | |
| Sep 14, 2022 | BFLY Butterfly Network, Inc. | Quander Troy | SVP, Regulatory And Quality | Sell | 1,493 | $6.19 | $9,245.70 | -0.9% | -56.2% | -72.4% | |
| Sep 14, 2022 | TMCI Treace Medical Concepts, Inc. | Bays F Barry80 | Director | Sell | 68,357 | $23.22 | $1,587,109.99 | -1.0% | -0.1% | -36.8% | |
| Sep 13, 2022 | SRTS Sensus Healthcare, Inc. | Sardano Michael73 | President And General Counsel | Sell | 5,000 | $14.13 | $70,627.50 | -9.2% | -56.4% | -80.1% | |
| Sep 12, 2022 | RBOT Vicarious Surgical Inc. | Liang Philip45 | Director | Sell | 11,943 | $4.48 | $53,552.41 | -1.0% | -45.5% | -80.1% | |
| Sep 12, 2022 | VERO Venus Concept Inc. | Georgiadis Anna | VP, Global Hr | Buy | 12,782 | $0.71 | $9,082.89 | New | -55.8% | -84.4% | |
| Sep 12, 2022 | MASS 908 Devices Inc. | Brown Christopher D.85 | Chief Technology Officer | Sell | 20,000 | $19.58 | $391,600.00 | -2.2% | -57.9% | -67.6% | |
| Sep 12, 2022 | SONX Sonendo, Inc. | General Atlantic, L.P.71 | Director, 10% Owner | Sell | 300,000 | $0.99 | $297,000.00 | -10.3% | - | - | |
| Sep 12, 2022 | IRTC Irhythm Holdings, Inc. | Bairey Merz Cathleen Noel | Director | Sell | 90 | $159.77 | $14,379.30 | -1.8% | -36.8% | -39.4% | |
| Sep 12, 2022 | INFU Infusystem Holdings, Inc | Lehman Gregg Owen68 | Director | Sell | 15,257 | $7.79 | $118,817.79 | -93.6% | +15.7% | +31.1% | |
| Sep 9, 2022 | RGEN Repligen Corp | Dawes Karen A63 | Director | Sell | 775 | $227.17 | $176,056.75 | -1.0% | -25.6% | -30.9% | |
| Sep 9, 2022 | WRBY Warby Parker Inc. | Miller Steven Clive62 | Chief Financial Officer | Sell | 4,957 | $15.10 | $74,850.70 | -2.9% | +4.8% | -25.4% | |
| Sep 9, 2022 | WRBY Warby Parker Inc. | Blumenthal Neil Harris66 | Co-chief Executive Officer | Sell | 5,099 | $15.10 | $76,994.90 | -98.0% | +4.8% | -25.4% | |
| Sep 9, 2022 | RBOT Vicarious Surgical Inc. | Liang Philip45 | Director | Sell | 8,057 | $4.43 | $35,668.34 | -0.6% | -39.0% | -78.5% | |
| Sep 9, 2022 | WRBY Warby Parker Inc. | Gilboa David Abraham62 | Co-chief Executive Officer | Sell | 5,252 | $15.10 | $79,305.20 | -95.7% | +4.8% | -25.4% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.